Discovery leaps on Surfaxin launch update

Discovery Laboratories Inc. (NASDAQ:DSCO) gained $0.73 (37%) to $2.70 on Friday after confirming that it plans to launch Surfaxin lucinactant this quarter after FDA agreed to the company's updated pro...